Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Enterovirus A71 2A-S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines.

Journal of medical virology - 1 Aug 2024

Zhang Peng, Zou Wenjia, Xiong Rui, Wu Yong, Fan Changfa, Peng Yihong

Abstract excerpt

Enteroviruses are important human pathogens with diverse serotypes, posing a major challenge to develop vaccines for individual serotypes, the success of polio vaccines in controlling and eradicating polio, along with the recent emergence and high prevalence of enterovirus-caused infectious diseases, highlights the importance of enterovirus vaccine development. Given our previous report on enteroviruses weakened...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Enterovirus A, Human

Share to Enterovirus Infections

Share to Vaccines, Attenuated

Share to Viral Load

Share to Viral Vaccines

Source

Identifiers

PMID: 39081166
DOI: 10.1002/jmv.29838

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Enterovirus A71 2A-S125A acts as an attenuated vaccine candidate, indicating a universal approach in developing enterovirus vaccines.PMID 39081166Read ↗

EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.Semantic proximity Read ↗

Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.Semantic proximity Read ↗

Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.Semantic proximity Read ↗

A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical modelsSemantic proximity Read ↗

Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71.Semantic proximity Read ↗

TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.Semantic proximity Read ↗

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastorisSemantic proximity Read ↗

Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and routeSemantic proximity Read ↗

Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.Semantic proximity Read ↗

Mapping Attenuation Determinants in Enterovirus-D68Semantic proximity Read ↗

CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2Semantic proximity Read ↗

Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.